Deus Medical Sustamed 250 Lab Test Results

Anabolic Lab
November 19, 2020

Summary

The product Sustamed 250, manufactured by Deus Medical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number KX08947 (Manufactured 10/2020), was submitted by the reseller DeusPower.Shop and analyzed by Janoshik Analytical. The analysis measured a total concentration of 259.04 mg/ml, exceeding the labeled claim of 250 mg/ml by 3.62%.

The testing process began on 13 November 2020, with the sample received on 18 November 2020, and analysis completed on 19 November 2020. The test results confirm accurate dosing but highlight the importance of further scrutiny, as reseller-submitted samples may represent select high-quality batches rather than typical product consistency. Independent third-party testing remains crucial for comprehensive validation. This report aims to promote harm reduction and informed decision-making.


Detailed Report

Product Overview

  • Manufacturer: Deus Medical
  • Product Name: Sustamed 250
  • Active Ingredient: Testosterone blend (Propionate, Phenylpropionate, Isocaproate, Decanoate)
  • Batch Number: KX08947 (Manufactured 10/2020)
  • Expiration Date: Not provided
  • Delivery Method: Injectable

Sample Acquisition and Testing

  • Task Number: #09085
  • Testing Ordered: 13 November 2020
  • Sample Received: 18 November 2020
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: DeusPower.Shop (Reseller)
  • Analysis Paid For By: DeusPower.Shop

Testing Results

  • Specification: 250 mg/ml (as stated on the label)
  • Measured Concentration: 259.04 mg/ml
  • Accuracy: 103.62% (3.62% above the label claim)
  • Breakdown:
    • Testosterone Propionate: 29.97 mg/ml
    • Testosterone Phenylpropionate: 60.35 mg/ml
    • Testosterone Isocaproate: 60.22 mg/ml
    • Testosterone Decanoate: 108.5 mg/ml

Verification Details


Evaluation of Reseller-Submitted Testing

This analysis confirms the high accuracy of the tested product but requires careful evaluation due to its submission and funding by the reseller DeusPower.Shop. Resellers often select optimal batches for testing, which may not represent typical product quality. Independent third-party testing across multiple batches remains essential for unbiased validation.


Conclusion

The analysis confirms that Sustamed 250 is slightly overdosed, with a measured concentration of 259.04 mg/ml. This result suggests strong quality control for this batch but underscores the need for additional testing to ensure consistent dosing across the product line. This report serves as an educational resource to support harm reduction and informed consumer decisions.


Disclaimer

This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.